[Measurement of the secretion of growth hormone in patients with thalassemia major].
De Luca
G
G
Cattedra di Fisiopatologia Endocrina, Centro Sanitario, Università degli Studi della Calabria, Cosenza.
Maggiolini
M
M
Bria
M
M
Caracciolo
M
M
Lanzino
M
M
Le Pera
M
M
Brancati
C
C
Andò
S
S
D000293:Adolescent; D001803:Blood Transfusion; D015913:Chelation Therapy; D002648:Child; D003131:Combined Modality Therapy; D003676:Deferoxamine / Q000627:therapeutic use; D004392:Dwarfism / Q000209:etiology / Q000503:physiopathology; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D008297:Male; D011627:Puberty; D011729:Pyridostigmine Bromide; D013004:Somatostatin / Q000502:physiology; D017086:beta-Thalassemia / Q000150:complications / Q000503:physiopathology* / Q000628:therapy
D013004:Somatostatin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D003676:Deferoxamine; D011729:Pyridostigmine Bromide
Valutazione della secrezione dell'ormone della crescita (GH) in soggetti affetti da thalassemia major.